Citius Pharmaceuticals, Inc. Operating Lease, Expense
Citius Pharmaceuticals, Inc. (CTXR) reported Operating Lease, Expense of $48.53 thousand for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-08-14
- Citius Pharmaceuticals, Inc. operating lease, expense for the quarter ending 2026-06-30 was $15.62K, a 19.90% increase year-over-year.
- Citius Pharmaceuticals, Inc. operating lease, expense for the quarter ending 2026-03-31 was $16.43K, a 344.52% increase year-over-year.
- Citius Pharmaceuticals, Inc. operating lease, expense for the quarter ending 2025-12-31 was $16.48K, a 238.46% increase year-over-year.
- Citius Pharmaceuticals, Inc. operating lease, expense for the quarter ending 2025-09-30 was $17.46K, a 190.05% increase year-over-year.
- Citius Pharmaceuticals, Inc. operating lease, expense for fiscal 2025 was $39.05K, a 27.44% increase from fiscal 2024.
- Citius Pharmaceuticals, Inc. operating lease, expense for fiscal 2024 was $30.64K, a 35.04% decline from fiscal 2023.
- Citius Pharmaceuticals, Inc. operating lease, expense for fiscal 2023 was $47.18K, a 23.99% decline from fiscal 2022.
- Citius Pharmaceuticals, Inc. operating lease, expense for fiscal 2022 was $62.07K, a 17.73% decline from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 6 month as first filed | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $15.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-14 | $32.05K derived: sum of 2 quarters · filed 2026-08-14 | $48.53K 10-Q · filed 2026-08-14 | $66.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $16.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | $32.92K 10-Q · filed 2026-05-15 | $50.38K derived: sum of 3 quarters · filed 2026-05-15 | $63.40K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $16.48K 10-Q · filed 2026-02-13 | $33.95K derived: sum of 2 quarters · filed 2026-02-13 | $46.97K derived: sum of 3 quarters · filed 2026-08-14 | $50.67K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-09-30 | $17.46K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-23 | $30.49K derived: sum of 2 quarters · filed 2026-08-14 | $34.18K derived: sum of 3 quarters · filed 2026-08-14 | $39.05K 10-K · filed 2025-12-23 | |
| 2025-06-30 | $13.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-14 | $16.72K derived: sum of 2 quarters · filed 2026-08-14 | $21.59K 10-Q · filed 2026-08-14 | $27.61K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $3.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | $8.57K 10-Q · filed 2026-05-15 | $14.59K derived: sum of 3 quarters · filed 2026-05-15 | $21.72K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $4.87K 10-Q · filed 2026-02-13 | $10.89K derived: sum of 2 quarters · filed 2026-02-13 | $18.02K derived: sum of 3 quarters · filed 2026-02-13 | $26.24K derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-09-30 | $6.02K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-23 | $13.15K derived: sum of 2 quarters · filed 2025-12-23 | $21.37K derived: sum of 3 quarters · filed 2025-12-23 | $30.64K 10-K · filed 2025-12-23 | |
| 2024-06-30 | $7.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-12 | $15.35K derived: sum of 2 quarters · filed 2025-08-12 | $24.62K 10-Q · filed 2025-08-12 | $34.94K derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | $8.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | $17.49K 10-Q · filed 2025-05-14 | $27.80K derived: sum of 3 quarters · filed 2025-05-14 | $27.80K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $9.28K 10-Q · filed 2025-02-14 | $19.59K derived: sum of 2 quarters · filed 2025-02-14 | $19.59K derived: sum of 3 quarters · filed 2025-02-14 | $43.20K derived: sum of 4 quarters · filed 2025-02-14 | |
| 2023-09-30 | $10.31K derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-27 | $10.31K derived: sum of 2 quarters · filed 2024-12-27 | $33.93K derived: sum of 3 quarters · filed 2024-12-27 | $47.18K 10-K · filed 2024-12-27 | |
| 2023-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | $23.61K derived: sum of 2 quarters · filed 2024-08-12 | $36.86K 10-Q · filed 2023-08-14 | $51.05K derived: sum of 4 quarters · filed 2024-08-12 | |
| 2023-03-31 | $23.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $36.86K 10-Q · filed 2024-08-12 | $25.54K 10-Q · filed 2023-05-12 | $51.05K derived: sum of 3 quarters · filed 2024-08-12 | $66.14K derived: sum of 4 quarters · filed 2024-08-12 |
| 2022-12-31 | $13.25K 10-Q · filed 2024-02-14 | $27.44K derived: sum of 2 quarters · filed 2024-02-14 | $42.53K derived: sum of 3 quarters · filed 2024-02-14 | $58.49K derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-09-30 | $14.19K derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-29 | $29.28K derived: sum of 2 quarters · filed 2023-12-29 | $45.24K derived: sum of 3 quarters · filed 2023-12-29 | $62.07K 10-K · filed 2023-12-29 | |
| 2022-06-30 | $15.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | $31.05K derived: sum of 2 quarters · filed 2023-08-14 | $47.88K 10-Q · filed 2023-08-14 | $65.55K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $15.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | $32.79K 10-Q · filed 2023-05-12 | $50.46K derived: sum of 3 quarters · filed 2023-05-12 | $68.94K derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $16.83K 10-Q · filed 2023-02-10 | $34.49K derived: sum of 2 quarters · filed 2023-02-10 | $52.97K derived: sum of 3 quarters · filed 2023-02-10 | $72.24K derived: sum of 4 quarters · filed 2023-02-10 | |
| 2021-09-30 | $17.67K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | $36.15K derived: sum of 2 quarters · filed 2022-12-22 | $55.41K derived: sum of 3 quarters · filed 2022-12-22 | $75.45K 10-K · filed 2022-12-22 | |
| 2021-06-30 | $18.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | $37.74K derived: sum of 2 quarters · filed 2022-08-11 | $57.78K 10-Q · filed 2022-08-11 | $78.57K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $19.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-12 | $39.30K 10-Q · filed 2022-05-12 | $60.09K derived: sum of 3 quarters · filed 2022-05-12 | $81.61K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $20.04K 10-Q · filed 2022-02-10 | $40.83K derived: sum of 2 quarters · filed 2022-02-10 | $62.34K derived: sum of 3 quarters · filed 2022-02-10 | $84.56K derived: sum of 4 quarters · filed 2022-02-10 | |
| 2020-09-30 | $20.79K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-15 | $42.31K derived: sum of 2 quarters · filed 2021-12-15 | $64.52K derived: sum of 3 quarters · filed 2021-12-15 | $87.30K 10-K · filed 2021-12-15 | |
| 2020-06-30 | $21.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-12 | $43.73K derived: sum of 2 quarters · filed 2021-08-12 | $66.51K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $22.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-13 | $45.00K 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $22.78K 10-Q · filed 2021-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |